Product NDC: | 62756-700 |
Proprietary Name: | Risperidone |
Non Proprietary Name: | Risperidone |
Active Ingredient(s): | .5 mg/1 & nbsp; Risperidone |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 62756-700 |
Labeler Name: | Sun Pharmaceutical Industries Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078464 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130413 |
Package NDC: | 62756-700-83 |
Package Description: | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62756-700-83) |
NDC Code | 62756-700-83 |
Proprietary Name | Risperidone |
Package Description | 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62756-700-83) |
Product NDC | 62756-700 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Risperidone |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20130413 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharmaceutical Industries Limited |
Substance Name | RISPERIDONE |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC] |